Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| B cell | 13 studies | 22% ± 6% | |
| naive B cell | 12 studies | 19% ± 4% | |
| endothelial cell | 11 studies | 22% ± 8% | |
| fibroblast | 7 studies | 22% ± 9% | |
| endothelial cell of artery | 6 studies | 18% ± 2% | |
| memory B cell | 6 studies | 20% ± 6% | |
| microglial cell | 6 studies | 23% ± 7% | |
| epithelial cell | 4 studies | 31% ± 10% | |
| macrophage | 4 studies | 20% ± 3% | |
| plasmacytoid dendritic cell | 4 studies | 23% ± 6% | |
| conventional dendritic cell | 3 studies | 21% ± 3% | |
| capillary endothelial cell | 3 studies | 19% ± 3% | |
| glomerular endothelial cell | 3 studies | 20% ± 1% | |
| pericyte | 3 studies | 17% ± 0% | |
| endothelial cell of vascular tree | 3 studies | 17% ± 1% | |
| GABAergic neuron | 3 studies | 21% ± 4% | |
| glutamatergic neuron | 3 studies | 25% ± 5% | |
| basal cell | 3 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2129.94 | 1445 / 1445 | 100% | 26.69 | 183 / 183 |
| lung | 100% | 2339.73 | 578 / 578 | 100% | 22.36 | 1154 / 1155 |
| ovary | 100% | 1583.93 | 180 / 180 | 100% | 22.78 | 429 / 430 |
| breast | 100% | 2383.11 | 459 / 459 | 99% | 27.85 | 1109 / 1118 |
| brain | 99% | 1189.50 | 2619 / 2642 | 100% | 21.07 | 703 / 705 |
| uterus | 100% | 1820.69 | 170 / 170 | 98% | 17.32 | 448 / 459 |
| stomach | 100% | 1242.68 | 358 / 359 | 97% | 19.06 | 278 / 286 |
| intestine | 100% | 2125.42 | 966 / 966 | 97% | 16.54 | 510 / 527 |
| thymus | 100% | 1516.35 | 653 / 653 | 97% | 15.45 | 584 / 605 |
| prostate | 100% | 1636.49 | 244 / 245 | 96% | 23.54 | 484 / 502 |
| pancreas | 97% | 882.73 | 318 / 328 | 99% | 17.98 | 176 / 178 |
| skin | 100% | 2052.27 | 1802 / 1809 | 96% | 21.97 | 453 / 472 |
| kidney | 100% | 1502.19 | 89 / 89 | 94% | 20.44 | 846 / 901 |
| bladder | 100% | 2297.38 | 21 / 21 | 94% | 13.77 | 472 / 504 |
| adrenal gland | 100% | 1278.11 | 258 / 258 | 92% | 11.63 | 211 / 230 |
| liver | 88% | 607.93 | 200 / 226 | 92% | 11.66 | 375 / 406 |
| adipose | 100% | 2973.03 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2622.02 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1122.29 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.35 | 1 / 1 |
| muscle | 99% | 908.40 | 792 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 16.54 | 44 / 45 |
| heart | 97% | 1206.43 | 831 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 76% | 790.47 | 705 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 73% | 6.91 | 58 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 69% | 10.27 | 20 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0031333 | Biological process | negative regulation of protein-containing complex assembly |
| GO_0009953 | Biological process | dorsal/ventral pattern formation |
| GO_0048264 | Biological process | determination of ventral identity |
| GO_0046329 | Biological process | negative regulation of JNK cascade |
| GO_0043508 | Biological process | negative regulation of JUN kinase activity |
| GO_0005575 | Cellular component | cellular_component |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0019904 | Molecular function | protein domain specific binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0035091 | Molecular function | phosphatidylinositol binding |
| Gene name | AIDA |
| Protein name | AIDA protein Axin interactor, dorsalization-associated protein (Axin interaction partner and dorsalization antagonist) |
| Synonyms | C1orf80 |
| Description | FUNCTION: Acts as a ventralizing factor during embryogenesis. Inhibits axin-mediated JNK activation by binding axin and disrupting axin homodimerization. This in turn antagonizes a Wnt/beta-catenin-independent dorsalization pathway activated by AXIN/JNK-signaling (By similarity). . |
| Accessions | ENST00000340020.11 [Q96BJ3-1] ENST00000355727.3 [Q96BJ3-3] Q96BJ3 B7ZW30 |